HIGH THERAPEUTIC EFFICIENCY WITH LEDIPASVIR/SOFOSBUVIR FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C IN PORTUGAL

被引：0
|
作者：
Ferreira, D. [1 ]
Felix, J. [1 ]
Almeida, J. [1 ]
Mota, M. [1 ]
Afonso Silva, M. [1 ]
Silva, P. [1 ]
Vandewalle, B. [1 ]
Velosa, J. [2 ]
Marinho, R. [2 ]
Aldir, I [3 ]
Carvalho, A. [4 ]
Valente, C. [5 ]
Macedog, G. [6 ]
Sarmento e Castro, R. [7 ]
Pedroto, I [8 ]
机构：
[1] Exigo Consultores, Alhos Vedros, Portugal
[2] Ctr Hosp Lisboa Norte, Hosp Santa Maria, EPE, Lisbon, Portugal
[3] Ctr Hosp Lisboa Ocident, Hosp Egas Moniz, Lisbon, Portugal
[4] Ctr Hosp & Univ Coimbra, Coimbra, Portugal
[5] Ctr Hosp & Univ Coimbra, EPE, Coimbra, Portugal
[6] Hosp Sao Joao, Oporto, Portugal
[7] Ctr Hosp Porto, EPE, Oporto, Portugal
[8] Ctr Hosp Porto, Oporto, Portugal
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1924
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN14
引用
收藏
页码：A578 / A578
页数：1
相关论文
共 50 条
  • [21] LEDIPASVIR / SOFOSBUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C: A COST-EFFECTIVENESS ANALYSIS ACROSS DIFFERENT GENOTYPE 1 CLINICAL SUBGROUPS
    Felix, J.
    Almeida, J.
    Ferreira, D.
    Mota, M.
    Afonso-Silva, M.
    Silva, P.
    Vandewalle, B.
    Velosa, J.
    Marinho, R.
    Aldir, I
    Carvalho, A.
    Valente, C.
    Macedo, G.
    Sarmento e Castro, R.
    Pedroto, I
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A585 - A585
  • [22] Ledipasvir-Sofosbuvir: A Once-Daily Oral Treatment Option for Chronic Hepatitis C Virus Genotype 1 Infection
    Jensen, Christopher M.
    Holle, Lisa M.
    [J]. PHARMACOTHERAPY, 2016, 36 (05): : 562 - 574
  • [23] Efficacy and safety of sofosbuvir and ledipasvir in the treatment of elderly Japanese patients with hepatitis C genotype 1 infected
    Nagata, Kenji
    Hasuike, Satoru
    Takaishi, Yuuka
    Yamada, Yuuri
    Tsuchimochi, Mai
    Nakamura, Kennichi
    Shimoda, Kazuya
    Sueta, Mitsue
    Kusumoto, Kazunori
    Ochiai, Toshimasa
    Kato, Junya
    Komada, Naoto
    Oozono, Yoshinori
    Hirono, Shuichi
    Kuroki, Kazuo
    Shigehira, Masafumi
    Shimoda, Kazuya
    [J]. HEPATOLOGY, 2016, 64 : 953A - 953A
  • [24] Effectiveness of Ledipasvir/Sofosbuvir in Genotype 1 Hepatitis C Treatment-Naive Heavy Alcohol Drinkers
    Mailliard, Mark E.
    Kos, Mary Beth
    Ganesan, Murali
    Osna, Natalia
    [J]. HEPATOLOGY, 2018, 68 : 374A - 375A
  • [25] Ledipasvir-Sofosbuvir-Combination in chronic Hepatitis C?
    Escher, Markus
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (25-26) : 13331 - 13331
  • [26] Hepatitis B reactivation in chronic hepatitis C patients during treatment with ledipasvir and sofosbuvir
    Ou, Pengcheng
    Chen, Jun
    [J]. ANTIVIRAL THERAPY, 2018, 23 (03) : 283 - 284
  • [27] Efficiency of treatment in naive patients with the first genotype of chronic viral hepatitis "C" with sofosbuvir plus ledipasvir combination in the industrial center of Eastern Siberia
    Tsukanov, Vladislav
    Borisov, Alexander
    Savchenko, Andrey
    Tonkikh, Julia
    Vasyutin, Alexander
    Tikhonova, Elena
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 694 - 694
  • [28] Perspectives of fixed daily dose of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C
    Floreani, Annarosa
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (06) : 801 - 804
  • [29] Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection
    Einsiedel, Hagen Graf
    Christiansen, Holger
    Wiegand, Johannes
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (12) : 1373 - 1373
  • [30] Ledipasvir and sofosbuvir:Interferon free therapy for hepatitis C virus genotype 1 infection
    Yasir Waheed
    [J]. World Journal of Virology, 2015, (01) : 33 - 35
12345